MedPath

Evaluation of the effect of vitamin C on some blood indicators of dialysis patients

Phase 2
Conditions
Chronic kidney disease.
Chronic kidney disease, stage 4 (severe)
N18.4
Registration Number
IRCT20100102002954N25
Lead Sponsor
Shahroud University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
106
Inclusion Criteria

Patients with definitive diagnosis of chronic kidney disease and need dialysis;
Age range 15-65 years;
History of dialysis for at least six consecutive months;
Stable vital signs;
Have a controlled and consistent diet throughout the study;
Conscious consent to participate in research.

Exclusion Criteria

Existence of digestive problems such as severe nausea and vomiting;
Existence of severe and relatively severe coagulation problems;
Existence of chronic heart and liver disease at the same time;
Take any vitamin C supplements in the past month;
Any changes in diet without notice during the study;
Withdrawal or regret of conducting research at any stage of research.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Measurement of serum potassium. Timepoint: Once a month. Method of measurement: Standard laboratory method.;Measurement of serum calcium. Timepoint: Once a month. Method of measurement: Standard laboratory method.;Blood sugar measurement. Timepoint: Once a month. Method of measurement: Standard laboratory method.;Measurement of hemoglobin. Timepoint: Once a month. Method of measurement: Standard laboratory method.
Secondary Outcome Measures
NameTimeMethod
Dialysis adequacy measurement. Timepoint: Once a month. Method of measurement: Dialysis adequacy indicators KT/V.
© Copyright 2025. All Rights Reserved by MedPath